Free Trial
NASDAQ:EGRX

Eagle Pharmaceuticals (EGRX) Stock Price, News & Analysis

Eagle Pharmaceuticals logo
$3.00 +0.11 (+3.63%)
As of 07/3/2025 09:30 AM Eastern

About Eagle Pharmaceuticals Stock (NASDAQ:EGRX)

Key Stats

Today's Range
$2.36
$3.00
50-Day Range
$1.65
$3.00
52-Week Range
$1.50
$3.00
Volume
620 shs
Average Volume
8,193 shs
Market Capitalization
$38.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

EGRX Stock News Headlines

EGRX Eagle Pharmaceuticals, Inc. - Seeking Alpha
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Eagle Pharmaceuticals to Delist from Nasdaq
See More Headlines

EGRX Stock Analysis - Frequently Asked Questions

Eagle Pharmaceuticals' stock was trading at $0.50 on January 1st, 2025. Since then, EGRX shares have increased by 500.0% and is now trading at $3.00.

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) issued its quarterly earnings results on Tuesday, November, 9th. The specialty pharmaceutical company reported $0.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.44) by $1.00. The specialty pharmaceutical company had revenue of $39.85 million for the quarter, compared to the consensus estimate of $46.70 million.

Shares of EGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eagle Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Netflix (NFLX), Exxon Mobil (XOM), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
11/09/2021
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EGRX
Fax
N/A
Employees
100
Year Founded
2007

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$257.55 million
Cash Flow
$7.50 per share
Price / Cash Flow
0.40
Price / Book
N/A

Miscellaneous

Free Float
9,234,000
Market Cap
$38.96 million
Optionable
No Data
Beta
0.83

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:EGRX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners